Medicare to cover “off-label” drugs for cancer care
Medicare has quietly expanded its coverage for cancer drugs to include some treatments that haven’t gotten the Food and Drug Administration’s full seal of approval.
Medicare has quietly expanded its coverage for cancer drugs to include some treatments that haven’t gotten the Food and Drug Administration’s full seal of approval.